Dr. KinyasHair Clinic · IstanbulLibrary ←
Science and Research Centre / Hair Loss and Treatments

Dr. Kinyas Hair Clinic · Science and Research Centre

PRP and Transplantation: Possible Benefits, Evidence Limits and Expectations

If PRP is proposed, first ask what problem it should address for you, rather than how many sessions. Some studies report benefits, but do not make PRP mandatory or guarantee outcomes.

Which benefit is expected?

PRP is platelet-enriched plasma prepared from a person’s blood. Growth-factor biology justifies research, not clinical success by itself. Treating existing AGA hair, intraoperative application and graft storage are different uses; evidence for one does not prove another equally effective. [1], [2]

Clarify whether the target is existing hair or early postoperative findings. Support cannot replace distribution and donor management. Positive PRP findings do not show it compensates for unrealistic hairlines, inadequate reserves or surgical injury.

Why is certainty limited despite positive studies?

A 2025 transplant-specific systematic review found three studies totalling 217 people: two randomised and one nonrandomised. Protocols and measurements differed; no pooled effect percentage was calculated. A single PRP success rate is therefore inappropriate. [1]

Xue and colleagues assigned 30 people to two groups. Both received FUE and medication; PRP was added in the experimental group, with favourable findings. Small size, six-month assessment and concurrent treatments limit generalisation to everyone or other methods. This does not make standalone PRP superior to all treatments. [2]

Reading the percentage in the 2026 study

Dawane and colleagues’ randomised trial abstract in 60 men reports all PRP participants exceeded a particular regrowth threshold at six months. This does not mean every graft survived. Patient proportions reaching a threshold and graft-survival proportions have different denominators. [3]

Only the indexed abstract could be assessed; full text and detailed measurements must not be presented as read. Findings cannot guarantee every modern DHI outcome. Ask what method, comparator and follow-up underlie any proposed claim.

What do other clinical studies show?

The accessible abstract of a 2023 study of 147 patients compares groups with and without PRP. Record review lacks randomisation’s protections: baseline differences and treatment selection can affect results. Only the abstract was available; detailed numerical findings were not used. [4]

In a 2020 surgical series of 247 people, high satisfaction was more frequent with PRP. Surgical technique and other care also changed. Satisfaction is not survival, and improvement cannot all be attributed to PRP. [5]

Relevant methods and results of a 2024 study of 24 people were examined. Groups were small and some labels/percentages conflict across abstract, body and figures. No definite effect percentage or routine schedule was transferred; findings need caution. [6]

Satisfaction, density and survival differ

Satisfaction matters, but length, styling, lighting and existing hair influence photographs. Survival requires definitions of implanted units and follow-up measurements. Increased shaft density alone does not prove every graft survived. [2], [3], [5]

Do not relabel outcomes to create stronger promises. Six-month findings do not predetermine twelve-month appearance or long-term permanence for everyone. Discuss concurrent drugs, baseline images and standard follow-up when assessing PRP.

Are all PRP procedures identical?

Collection, preparation, cellular content, activation, timing and repeats differ between studies. One shared name does not establish equivalent products or outcomes. Without comparison, neither one kit nor more sessions can be declared superior. [1], [2], [5]

Study procedures are not reproduced as prescriptions. Research preparation, storage and concurrent medications are not the clinic’s established protocol. Product selection, sterile preparation and suitability require healthcare professionals, not home treatment.

Questions before deciding

Ask the target for your diagnosis, alternatives without PRP, how benefit will be measured and when reviewed. Share prior responses and methods you decline. Consider benefit alongside cost and treatment burden. [1], [2] (clinical decision framework)

Discuss illnesses, bleeding history and medicines beforehand. This page does not advise stopping blood thinners or other drugs yourself. Small studies cannot exclude rare problems or establish safety for every health group. Unexpected, increasing or widespread symptoms need assessment by the treating team.

Its place in transplant planning

PRP may be an optional adjunct for a suitable person, not a mandatory package or prerequisite for successful surgery. Planning, existing-hair assessment and follow-up are separate decisions. A favourable group average is not a personal promise. [1], [2], [3], [4], [5], [6]

If proposed by Dr. Kinyas, ask for its individual rationale in your plan. This text verifies no specific clinic kit, session count or routine protocol. Clarify these against current practice.

What the studies do and do not establish
SourceDesign / accessInterpretation limit
2025 systematic review [1]3 studies, 217 peopleDifferent protocols; no pooled success percentage.
Xue et al. [2]30 people; randomised; relevant full textMedication and FUE in both arms; not standalone PRP.
Dawane et al. [3]60 men; randomised; abstract onlyPatients reaching a threshold does not mean every graft survived.
Zhao and Cao [4]147 records; abstract accessNo full text; not counted as a randomised trial.
Fattah [5]247 people; multiple surgical changesSatisfaction gains cannot be isolated as PRP effects alone.
El-Sakka et al. [6]24 people; relevant methods/resultsDescribed as randomised; limited methods detail and reporting inconsistencies. No definite rate transferred.

References and access limitations

This article is based on a targeted review of sources; it is not an original systematic review.

  1. Sindhusen S, Tawanwongsri W, Eden C. Efficacy of Platelet-Rich Plasma as an Adjunct to Hair Transplantation: A Systematic Review. Cureus. 2025;17:e94116. DOI: 10.7759/cureus.94116.

    Systematic review. Abstract and accessible body examined. Not all primary studies were independently assessed. Selection criteria exclude some literature.

  2. Xue P et al. A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation for Patients With Androgenetic Alopecia. J Cosmet Dermatol. 2025;24:e16665; online 18 November 2024. DOI: 10.1111/jocd.16665.

    Randomised clinical trial. Methods, relevant results and declarations accessed. 15/15 people; six months. No conflicts declared. Research protocol is not the clinic’s prescription.

  3. Dawane PV et al. Efficacy of Intraoperative Platelet-Rich Plasma in Follicular Unit Extraction Hair Transplantation: A Prospective Study. J Maxillofac Oral Surg. 2026;25:1166–1172. DOI: 10.1007/s12663-026-02997-8.

    Randomised trial; abstract level. 30/30 men, six months. Full text inaccessible; PMCID text listed for 1 August 2027. No relevant conflicts declared.

  4. Zhao L, Cao D. Application of hair transplantation combined with platelet-rich plasma injection for the treatment of androgenic alopecia. Eur J Dermatol. 2023. DOI: 10.1684/ejd.2023.4560.

    Record comparison, abstract only. Abstract describes a record review; difference from a later review’s design classification noted.

  5. Fattah JH. How We Improved Our Results of Hair Transplantation. J Clin Rev Case Rep. 2020;5(9):413–421.

    Observational surgical series. PRP table 140/107; steroid table 134/113. DOI omitted because unverified.

  6. El-Sakka DM, Ahmed HT, Aly MS. Evaluation of Clinical Outcome of Hair Restoration by the Follicular Unit Extraction (FUE) Technique With Versus Without Adding (PRP). Egypt J Plast Reconstr Surg. 2024;48(3):171–182.

    Small comparative study. Methods say randomised but allocation detail is limited. Satisfaction/event labels are inconsistent. No disclosure is not independent funding verification; DOI unverified.

← Back to section
WhatsApp
DR. KINYAS HAIR CLINIC

Quick Contact

Leave your details and we will contact you through your preferred channel.

How should we contact you?

Dr. Kinyas Hair Clinic uses your details to respond to your request and contact you.